Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-17
DOI
10.3389/fimmu.2019.03078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tolerating Factor VIII: Recent Progress
- (2020) Sebastien Lacroix-Desmazes et al. Frontiers in Immunology
- Role of the factor VIII-binding capacity of endogenous von Willebrand factor on the development of factor VIII inhibitors in patients with severe hemophilia A
- (2019) Yohann Repessé et al. HAEMATOLOGICA
- The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
- (2019) Shannon L. Meeks et al. HAEMOPHILIA
- Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice
- (2019) Maha Abdeladhim et al. CLINICAL IMMUNOLOGY
- Antigen‐specific in vitro expansion of factor VIII‐specific regulatory T cells induces tolerance in hemophilia A mice
- (2019) Bryn M. Smith et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins
- (2018) Ronit Mazor et al. AMERICAN JOURNAL OF PATHOLOGY
- Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia
- (2018) Richard S. Blumberg et al. BLOOD
- Dexamethasone promotes durable factor VIII -specific tolerance in hemophilia A mice via thymic mechanisms
- (2018) Maria T. Georgescu et al. HAEMATOLOGICA
- Immune tolerance induction: What have we learned over time?
- (2018) H.-H. Brackmann et al. HAEMOPHILIA
- Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
- (2018) M. Carcao et al. HAEMOPHILIA
- Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells
- (2018) Yong Chan Kim et al. JOURNAL OF AUTOIMMUNITY
- Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
- (2018) Ronit Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dexamethasone promotes durable factor VIII -specific tolerance in hemophilia A mice via thymic mechanisms
- (2018) Maria T. Georgescu et al. HAEMATOLOGICA
- The Future of Bypassing Agents for Hemophilia with Inhibitors in the Era of Novel Agents
- (2018) Amy D. Shapiro et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Vaccinations are not associated with inhibitor development in boys with severe haemophilia A
- (2017) H. Platokouki et al. HAEMOPHILIA
- From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance
- (2017) David W. Scott Frontiers in Immunology
- T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire
- (2016) R. A. Ettinger et al. BLOOD
- FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII
- (2016) Jeongheon Yoon et al. BLOOD
- Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
- (2016) S. W. Pipe et al. BLOOD
- Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A
- (2016) Jesse D. Lai et al. BLOOD
- Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
- (2016) Sriram Krishnamoorthy et al. CELLULAR IMMUNOLOGY
- Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation
- (2016) Ai-Hong Zhang et al. CELLULAR IMMUNOLOGY
- Extended half-life factor VIII for immune tolerance induction in haemophilia
- (2016) L. M. Malec et al. HAEMOPHILIA
- A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
- (2016) Midori Shima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein
- (2016) Charles L. Groomes et al. PEDIATRIC BLOOD & CANCER
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Factor VIII gene variants and inhibitor risk in African American hemophilia A patients
- (2015) D. Gunasekera et al. BLOOD
- Harnessing nanoparticles for immune modulation
- (2015) Daniel R. Getts et al. TRENDS IN IMMUNOLOGY
- Antibody-modified T cells: CARs take the front seat for hematologic malignancies
- (2014) M. V. Maus et al. BLOOD
- Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses
- (2014) Y. C. Kim et al. BLOOD
- Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients
- (2014) A. Lochan et al. HAEMOPHILIA
- From the Mouse Cage to Human Therapy: A Personal Perspective of the Emergence of T-bodies/Chimeric Antigen Receptor T Cells
- (2014) Zelig Eshhar HUMAN GENE THERAPY
- Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
- (2014) Roberto A. Maldonado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- Adoptive Transfer of Umbilical Cord Blood-Derived Regulatory T Cells and Early Viral Reactivation
- (2013) Claudio G. Brunstein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
- (2012) S. F. J. Whelan et al. BLOOD
- The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
- (2012) J. Astermark et al. BLOOD
- A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function
- (2012) S. L. Meeks et al. BLOOD
- F8haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
- (2012) J. Schwarz et al. HAEMOPHILIA
- In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
- (2012) Leslie P. Cousens et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Taking immunogenicity assessment of therapeutic proteins to the next level
- (2011) I.C. Büttel et al. BIOLOGICALS
- F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity
- (2011) C. H. MILLER et al. HAEMOPHILIA
- T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site
- (2011) E. A. JAMES et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells
- (2011) K. Baker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice
- (2010) A.-H. Zhang et al. BLOOD
- HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P
- (2010) R. A. ETTINGER et al. HAEMOPHILIA
- Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses
- (2009) R. A. Ettinger et al. BLOOD
- A role for thrombin in the initiation of the immune response to therapeutic factor VIII
- (2009) J. Skupsky et al. BLOOD
- B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses
- (2009) Kathleen P. Pratt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Inhibitors of Factor VIII in Black Patients with Hemophilia
- (2009) Kevin R. Viel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
- (2008) A. S. De Groot et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now